GLAXO news and notes GlaxoSmithKline Pakistan Limited
GlaxoSmithKline Pakistan Limited (GLAXO) news and notes: the SuperX note and what changed (5 items). The note is written by SuperX’s AI from its own figures. What changed is listed newest first.
What SuperX wrote about GLAXO
The price fell 0.57% on 13 Nov. The sector median fell 0.2% that day, with 10 of 15 scrips down.
On 5 Nov the price rose 3.19% on 4.88 times the usual volume. The pharmaceuticals sector rose the same way that day.
Nine-month EPS rose from 6.4 to 8.2 PKR, up 28.12%, for the period ended 30 Sep. Sales rose 16.96%.
Written by SuperX’s analyst desk from SuperX’s own figures, from the close of 13 Nov 2026. Each number was checked against those figures. Not advice.
What changed for GLAXO, newest first
- 13 Nov 2026Closed 336.36, -0.57%. Volume 97,426, 0.8 times the average of the 30 sessions before it, 126,411.
- 12 Nov 2026Margin financing (MTS) open on GLAXO: 163,355 shares.
- 6 Nov 2026Trend read changed to leaning up: above the 50-day average, below the 200-day; up 7.7% over 1 month.
- 29 Oct 2026Quarter ended 30 Sep 2026: earnings per share Rs 8.20, sales Rs 16.6 bn, up 28.1% on the same quarter a year before.
- NextAnnual results (to 31 Dec 2026) expected 9 Feb 2027 – 10 Apr 2027, a projection. An estimate from the dates of the last 8 filings.
As of the close of 13 Nov 2026. Closes and notices: PSX. Margin financing: NCCPL. Trend read: SuperX, from daily closes. Volume: against the average of the 30 sessions before the last. Next results: an estimate from the dates of the last 8 filings. Not advice.
More on GLAXO
- GLAXO share price and overview
- GLAXO dividend history
- Pharmaceuticals sector
- HALEON news and notes · Haleon Pakistan Limited
- AGP news and notes · AGP Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .